Roundview Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Sell
5,932
-49
-0.8% -$13.3K 0.1% 176
2025
Q4
$1.5M Buy
5,981
+164
+3% +$43.6K 0.09% 181
2025
Q3
$1.67M Buy
5,817
+31
+0.5% +$8.31K 0.11% 170
2025
Q2
$1.52M Sell
5,786
-100
-2% -$24.4K 0.1% 176
2025
Q1
$1.37M Sell
5,886
-31
-0.5% -$7.52K 0.1% 178
2024
Q4
$1.36M Buy
5,917
+73
+1% +$16.7K 0.09% 184
2024
Q3
$1.31M Sell
5,844
-446
-7% -$98K 0.09% 186
2024
Q2
$1.28M Buy
6,290
+10
+0.2% +$2.03K 0.1% 180
2024
Q1
$1.37M Sell
6,280
-22
-0.3% -$4.85K 0.11% 176
2023
Q4
$1.43M Sell
6,302
-352
-5% -$73.9K 0.13% 154
2023
Q3
$1.34M Sell
6,654
-2,231
-25% -$471K 0.13% 154
2023
Q2
$1.84M Buy
8,885
+34
+0.4% +$6.6K 0.18% 128
2023
Q1
$1.74M Buy
8,851
+130
+1% +$26.8K 0.18% 132
2022
Q4
$1.76M Sell
8,721
-70
-0.8% -$13.7K 0.2% 126
2022
Q3
$1.55M Sell
8,791
-225
-2% -$46.1K 0.2% 124
2022
Q2
$1.81M Sell
9,016
-55
-0.6% -$11.7K 0.22% 121
2022
Q1
$2.06M Buy
9,071
+144
+2% +$33.9K 0.21% 121
2021
Q4
$2.41M Buy
8,927
+41
+0.5% +$10.2K 0.24% 106
2021
Q3
$2.15M Buy
8,886
+182
+2% +$45.9K 0.24% 110
2021
Q2
$2.06M Buy
8,704
+523
+6% +$119K 0.23% 114
2021
Q1
$1.79M Buy
8,181
+323
+4% +$64.8K 0.23% 116
2020
Q4
$1.37M Buy
7,858
+117
+2% +$20.2K 0.19% 126
2020
Q3
$1.25M Sell
7,741
-38
-0.5% -$6.02K 0.2% 116
2020
Q2
$1.11M Sell
7,779
-3,919
-34% -$542K 0.19% 126
2020
Q1
$1.27M Buy
11,698
+3,966
+51% +$571K 0.27% 106
2019
Q4
$1.12M Buy
7,732
+975
+14% +$141K 0.21% 131
2019
Q3
$975K Buy
6,757
+669
+11% +$97.6K 0.21% 131
2019
Q2
$904K Buy
6,088
+245
+4% +$34.2K 0.2% 129
2019
Q1
$768K Buy
5,843
+21
+0.4% +$2.59K 0.18% 137
2018
Q4
$632K Buy
5,822
+1,376
+31% +$184K 0.18% 137
2018
Q3
$663K Hold
4,446
0.16% 147
2018
Q2
$686K Buy
4,446
+1,198
+37% +$181K 0.18% 144
2018
Q1
$451K Sell
3,248
-87
-3% -$12.8K 0.13% 159
2017
Q4
$457K Sell
3,335
-145
-4% -$19.2K 0.12% 166
2017
Q3
$451K Sell
3,480
-175
-5% -$23.3K 0.13% 161
2017
Q2
$484K Hold
3,655
0.14% 153
2017
Q1
$450K Sell
3,655
-29
-0.8% -$3.43K 0.14% 150
2016
Q4
$406K Hold
3,684
0.13% 154
2016
Q3
$435K Sell
3,684
-23
-0.6% -$2.71K 0.15% 142
2016
Q2
$415K Hold
3,707
0.15% 138
2016
Q1
$373K Sell
3,707
-82
-2% -$7.86K 0.14% 143
2015
Q4
$402K Hold
3,789
0.16% 127
2015
Q3
$353K Hold
3,789
0.15% 125
2015
Q2
$395K Sell
3,789
-99
-3% -$10.3K 0.15% 118
2015
Q1
$421K Hold
3,888
0.17% 113
2014
Q4
$360K Sell
3,888
-58
-1% -$5.12K 0.15% 121
2014
Q3
$345K Hold
3,946
0.16% 100
2014
Q2
$347K Hold
3,946
0.14% 123
2014
Q1
$333K Sell
3,946
-19,846
-83% -$1.58M 0.16% 105
2013
Q4
$1.87M Sell
23,792
-6,711
-22% -$572K 0.86% 37
2013
Q3
$2.6M Buy
30,503
+26,807
+725% +$2.26M 1.35% 19
2013
Q2
$318K Buy
+3,696
New +$307K 0.2% 94

Other funds holding LH

Roundview Capital's LH Position: Q1 2026 in Review

Roundview Capital reduced its Labcorp (LH) stake by 0.82% in Q1 2026, selling an estimated $13.3K and leaving 5,932 shares worth $1.58M. The position accounts for 0.1% of the portfolio, ranked #176.

Roundview Capital first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.6M in Q3 2013. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Roundview Capital held 5,932 shares of Labcorp worth $1.58M as of Q1 2026.
  • Roundview Capital sold 49 Labcorp shares in Q1 2026, an estimated $13.3K.
  • Labcorp made up 0.1% of Roundview Capital's portfolio in Q1 2026, its #176 holding.
  • Roundview Capital first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Roundview Capital's Labcorp position peaked at $2.6M in Q3 2013.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Roundview Capital's 13F filing for Q1 2026, filed 8 May 2026.